Interferon and B-cell Signatures Inform Precision Medicine in Lupus Nephritis
Introduction: Current therapeutic management of lupus nephritis (LN) fails to induce long-term remission in over 50% of patients, highlighting the urgent need for additional options. Methods: We analyzed differentially expressed genes (DEGs) in peripheral blood from patients with active LN (n = 41)...
Shranjeno v:
| Principais autores: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Elsevier
2024-06-01
|
| Serija: | Kidney International Reports |
| Teme: | |
| Online dostop: | http://www.sciencedirect.com/science/article/pii/S2468024924015857 |
| Oznake: |
Brez oznak, prvi označite!
|
